Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms
- 1 January 2021
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 192 (2) , 300-309
Abstract
Genetic studies in patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) are essential to establish the correct diagnosis and to optimise their management. Recently, it has been demonstrated that it is possible to detect molecular alterations analysing cell-free DNA (cfDNA) in plasma samples, which is known as liquid biopsy. We have assessed the molecular profile of a cohort of 107 MPN patients [33 polycythaemia vera (PV), 56 essential thrombocythaemia (ET), 14 primary myelofibrosis (PMF) and 4 unclassifiable MPN] by next-generation sequencing (NGS) using cfDNA and paired granulocyte DNA. A high concentration of cfDNA in plasma was observed in patients with high molecular complexity, inMPL-mutated cases, and in PMF patients. Targeted sequencing of cfDNA showed a comparable mutational profile (100% accuracy) to the one obtained in granulocytic DNA and a strong correlation was observed between the variant allele frequency (VAF) of gene mutations in both DNA sources. The median VAF detected in cfDNA (29 center dot 0%; range: 0 center dot 95-91 center dot 73%) was significantly higher than the VAF detected in granulocytes (median 25 center dot 2%; range: 0 center dot 10-95 center dot 5%), especially forMPLmutations (44 center dot 3% vs. 22 center dot 5%). In conclusion, our data support the use of cfDNA as a fast, sensitive and accurate strategy for performing molecular characterisation of MPN patients.Keywords
Funding Information
- Gilead Sciences (GLD16/00064)
- Instituto de Salud Carlos III (2017SGR205, PI16/0153, PI19/0005, PT17/0015/0011)
This publication has 30 references indexed in Scilit:
- Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcomeHaematologica, 2016
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-OriginCell, 2016
- Comparison of two next-generation sequencing kits for diagnosis of epileptic disorders with a user-friendly tool for displaying gene coverage, DeCovAApplied & Translational Genomics, 2015
- Circulating nucleic acids damage DNA of healthy cells by integrating into their genomesJournal of Biosciences, 2015
- Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo ModelPLOS ONE, 2012
- Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndromeBiochemical and Biophysical Research Communications, 2012
- Higher detection rate of JAK2 mutation using plasmaBlood, 2008
- A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosisLeukemia, 2007
- Increased Concentrations of Cell-Free Plasma DNA after Exhaustive ExerciseClinical Chemistry, 2004
- Horizontal transfer of oncogenes by uptake of apoptotic bodiesProceedings of the National Academy of Sciences, 2001